The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.

MLA

Badreldin, Waleed, et al. “The Efficacy of Irinotecan, Paclitaxel, and Oxaliplatin (IPO) in Relapsed Germ Cell Tumours with High-Dose Chemotherapy as Consolidation: A Non-Cisplatin-Based Induction Approach.” BJU International, vol. 117, no. 3, Mar. 2016, pp. 418–23. EBSCOhost, https://doi.org/10.1111/bju.13004.

APA

Badreldin, W., Krell, J., Chowdhury, S., Harland, S. J., Mazhar, D., Harding, V., Frampton, A. E., Wilson, P., Berney, D., Stebbing, J., & Shamash, J. (2016). The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach. BJU International, 117(3), 418–423. https://doi.org/10.1111/bju.13004

Chicago

Badreldin, Waleed, Jonathan Krell, Simon Chowdhury, Stephen J. Harland, Danish Mazhar, Victoria Harding, Adam E. Frampton, et al. 2016. “The Efficacy of Irinotecan, Paclitaxel, and Oxaliplatin (IPO) in Relapsed Germ Cell Tumours with High-Dose Chemotherapy as Consolidation: A Non-Cisplatin-Based Induction Approach.” BJU International 117 (3): 418–23. doi:10.1111/bju.13004.